Clincosm LogoSign in Get a demo

alport syndrome

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)

    Recruiting
    • Alport Syndrome
      • Paris, Île-de-France, France
        RaDiCo Eurbio-Alport
      Jun 22, 2023

      Baby Detect : Genomic Newborn Screening

      Recruiting
      • Congenital Adrenal Hyperplasia
      • +126 more
        • Liege, Wallonia, Belgium
          CRMN, Hôpital La Citadelle
        Jan 24, 2023

        Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy Trial in Worldwide (Sparsentan)

        Recruiting
        • Focal Segmental Glomerulosclerosis
        • +4 more
        • Wilmington, Delaware
        • +32 more
        Jan 10, 2023

        Alport Syndrome Trial in Clayton, Parkville, London (ELX-02)

        Recruiting
        • Alport Syndrome
        • Clayton, Victoria, Australia
        • +3 more
        Dec 19, 2022

        Alport Syndrome, Metformin Trial (Metformin, Placebo)

        Not yet recruiting
        • Alport Syndrome
        • Metformin
        • (no location specified)
        Dec 16, 2022

        IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome Trial in Worldwide (Atrasentan)

        Recruiting
        • IgA Nephropathy
        • +5 more
        • Huntsville, Alabama
        • +37 more
        Dec 1, 2022

        Alport Syndrome, Focal Segmental Glomerulosclerosis Trial in United States (R3R01)

        Recruiting
        • Alport Syndrome
        • Focal Segmental Glomerulosclerosis
        • Los Angeles, California
        • +10 more
        Aug 15, 2022

        Chronic Kidney Disease, Dialysis, Kidney Transplant Trial in Danville (Observational study - registry)

        Recruiting
        • Chronic Kidney Disease
        • +3 more
        • Observational study - registry
        • Danville, Pennsylvania
          Geisinger Clinic
        Aug 9, 2022

        Alport Syndrome Trial in United States (RG012)

        Completed
        • Alport Syndrome
        • La Mesa, California
        • +6 more
        Apr 21, 2022

        Alport Syndrome Trial in Minneapolis

        Recruiting
        • Alport Syndrome
          • Minneapolis, Minnesota
            University of Minnesota
          Mar 25, 2022

          Alport Syndrome Trial in Worldwide (Placebo Oral Capsule, Bardoxolone Methyl)

          Completed
          • Alport Syndrome
          • Placebo Oral Capsule
          • Bardoxolone Methyl
          • Birmingham, Alabama
          • +62 more
          Mar 22, 2022

          Alport Syndrome Trial in Shanghai (Ramipril)

          Not yet recruiting
          • Alport Syndrome
          • Shanghai, China
            Xinhua Hospital, Shanghai Jiao Tong University School of Medicin
          Nov 23, 2021

          Genotype-Phenotype Correlations in Patients With Alport Syndrome

          Recruiting
          • Alport Syndrome
            • Shanghai, China
              China Xinhua Hospital, Shanghai Jiao Tong University School of M
            Jun 24, 2021

            Microalbuminuria in Untreated Boys With Alport Syndrome

            Completed
            Has Results
            • Alport Syndrome
            • Kidney Disease
              • Minneapolis, Minnesota
                University of Minnesota
              Sep 22, 2017

              s in Alport Syndrome-A Feasibility Study

              Completed
              • Alport Syndrome
                • Minneapolis, Minnesota
                  University Of Minnesota
                Mar 21, 2018

                Alport Nephropathy Biomarker Studies

                Terminated
                • Alport Syndrome
                  • (no location specified)
                  Feb 10, 2014

                  Urinary Biomarkers of the Progression of Alport Kidney Disease

                  Completed
                  • Alport Syndrome
                    • Minneapolis, Minnesota
                      University of Minnesota
                    Jul 26, 2013

                    Alport Syndrome Trial in Ranica (ACE I, ATA II and Statins, Benazepril, Valsartan and Fluvastatin)

                    Completed
                    • Alport Syndrome
                    • ACE I, ATA II and Statins
                    • Benazepril, Valsartan and Fluvastatin
                    • Ranica, Bergamo, Italy
                      Clinical Research Center for Rare Diseases
                    Oct 5, 2009